PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Drug Anidulafungin (Eraxis)- FDA 11 1 0.00 -0.95 0.09 0.54
Cancer 1,053,491 Disease Drug Arranon (Nelarabine)- FDA 12 2 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 3 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.53
Cancer 1,053,491 Disease Target Glutathione Peroxidase 6 13 1 0.00 -0.96 0.08 0.53
Cancer 1,053,491 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.53
Cancer 1,053,491 Disease Drug Aredia (Pamidronate Disodium)- FDA 14 5 0.00 -0.80 0.36 0.56
Cancer 1,053,491 Disease Drug Aflibercept (Eylea)- FDA 14 7 0.00 -0.71 0.50 0.57
Cancer 1,053,491 Disease Drug Amifostine (Ethyol)- FDA 14 7 0.00 -0.71 0.50 0.57
Cancer 1,053,491 Disease Target Glutathione S-Transferase A3 15 4 0.00 -0.86 0.27 0.56
Cancer 1,053,491 Disease Target Beta-Adrenergic Receptor Kinase 2 15 1 0.00 -0.97 0.07 0.53
Cancer 1,053,491 Disease Target Vitamin D Receptor Interacting Protein 17 2 0.00 -0.94 0.12 0.54
Cancer 1,053,491 Disease Target beta-Cellulin 17 5 0.00 -0.84 0.29 0.56
Cancer 1,053,491 Disease Target BMP-2B 18 1 0.00 -0.97 0.06 0.53
Cancer 1,053,491 Disease Drug Abatacept (Orencia)- FDA 18 1 0.00 -0.97 0.06 0.53
Cancer 1,053,491 Disease Drug Aralen (Chloroquine)- FDA 19 3 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Target 464.1 19 2 0.00 -0.95 0.11 0.54
Cancer 1,053,491 Disease Target ALK Phos 19 1 0.00 -0.97 0.05 0.53
Cancer 1,053,491 Disease Drug Amitiza (Lubiprostone)- FDA 19 1 0.00 -0.97 0.05 0.53
Cancer 1,053,491 Disease Target Kallikrein-8 19 10 0.00 -0.69 0.53 0.57
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Target BRSK1 20 7 0.00 -0.81 0.35 0.56
Cancer 1,053,491 Disease Drug Ascorbic Acid (Vitamin C)- FDA 20 2 0.00 -0.95 0.10 0.54
Cancer 1,053,491 Disease Drug Dracorhodin 20 3 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Drug Aranesp (Darbepoetin Alfa)- FDA 20 6 0.00 -0.84 0.30 0.56
Cancer 1,053,491 Disease Target AMY2B 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target CAMK1D 21 2 0.00 -0.95 0.10 0.54
Cancer 1,053,491 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.53
Cancer 1,053,491 Disease Target CAMK2D 21 2 0.00 -0.95 0.10 0.54
Cancer 1,053,491 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.53
Cancer 1,053,491 Disease Target CAMK2B 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target DJ-1/PARK7 21 4 0.00 -0.90 0.19 0.55
Cancer 1,053,491 Disease Target Alpha Platelet-Derived Growth Factor Receptor 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target DC-CK1 22 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target Steroid Delta-Isomerase 22 1 0.00 -0.98 0.05 0.53
Cancer 1,053,491 Disease Drug Drupanin 22 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Disease Arthralgia Syndrome 23 7 0.00 -0.83 0.30 0.56
Cancer 1,053,491 Disease Drug Amitriptyline (Elavil)- FDA 23 1 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Target ACVR1B 23 6 0.00 -0.86 0.26 0.56
Cancer 1,053,491 Disease Disease Mucus In Stool 23 4 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Disease Carcinoma Head 24 9 0.00 -0.79 0.38 0.57
Cancer 1,053,491 Disease Target Cysteinyl Leukotriene Receptor 2 24 1 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Disease Cushings Syndrome 24 1 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Disease Gum Diseases 24 2 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Drug Ambien (Zolpidem Tartrate)- FDA 24 1 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Target Glutathione S-Transferase A2 25 2 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Drug Doxorubicin Analogue 25 8 0.00 -0.82 0.32 0.56
Cancer 1,053,491 Disease Disease Transplant Bone Marrow 26 2 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Target AURKC 26 4 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Drug Alprostadil (Prostin VR Pediatric)- FDA 26 2 0.00 -0.96 0.08 0.54